Elanco Animal Health Files Q1 2025 10-Q
Ticker: ELAN · Form: 10-Q · Filed: 2025-05-07T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
Elanco Animal Health filed its Q1 2025 10-Q, check financials for latest performance.
AI Summary
Elanco Animal Health Inc. filed its 10-Q for the period ending March 31, 2025. The filing covers the first quarter of 2025, detailing financial performance and business operations. Key financial data and operational updates for the period are presented.
Why It Matters
This filing provides investors and stakeholders with the latest financial results and operational insights for Elanco Animal Health, crucial for understanding the company's current performance and future outlook.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags or significant new risks disclosed.
Key Players & Entities
- Elanco Animal Health Inc. (company) — Filer of the 10-Q
- March 31, 2025 (date) — End of the reporting period
- 2025 Q1 (date) — Reporting quarter
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended March 31, 2025.
What is the company's Central Index Key (CIK)?
Elanco Animal Health Inc.'s Central Index Key (CIK) is 0001739104.
What is the company's fiscal year end?
Elanco Animal Health Inc.'s fiscal year ends on December 31.
What is the filing date of this 10-Q?
This 10-Q filing was filed as of May 7, 2025.
What is Elanco Animal Health's business address?
Elanco Animal Health's business address is 2500 Innovation Way, Greenfield, IN 46140.
From the Filing
0001739104-25-000042.txt : 20250507 0001739104-25-000042.hdr.sgml : 20250507 20250507090518 ACCESSION NUMBER: 0001739104-25-000042 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 81 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250507 DATE AS OF CHANGE: 20250507 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elanco Animal Health Inc CENTRAL INDEX KEY: 0001739104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 825497352 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38661 FILM NUMBER: 25919522 BUSINESS ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 BUSINESS PHONE: 877-352-6261 MAIL ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 10-Q 1 elan-20250331.htm 10-Q FOR THE PERIOD ENDED MARCH 31, 2025 elan-20250331 false 2025 Q1 0001739104 --12-31 1 1 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure elan:individual elan:employee iso4217:CHF elan:executive elan:board_member elan:claim elan:segment 0001739104 2025-01-01 2025-03-31 0001739104 2025-05-02 0001739104 2024-01-01 2024-03-31 0001739104 2025-03-31 0001739104 2024-12-31 0001739104 us-gaap:CommonStockMember 2023-12-31 0001739104 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001739104 us-gaap:RetainedEarningsMember 2023-12-31 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-12-31 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2023-12-31 0001739104 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-12-31 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001739104 2023-12-31 0001739104 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-01-01 2024-03-31 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2024-01-01 2024-03-31 0001739104 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-01-01 2024-03-31 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001739104 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001739104 us-gaap:CommonStockMember 2024-03-31 0001739104 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001739104 us-gaap:RetainedEarningsMember 2024-03-31 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-03-31 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2024-03-31 0001739104 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-03-31 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001739104 2024-03-31 0001739104 us-gaap:CommonStockMember 2024-12-31 0001739104 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001739104 us-gaap:RetainedEarningsMember 2024-12-31 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-12-31 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2024-12-31 0001739104 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-12-31 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001739104 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-01-01 2025-03-31 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2025-01-01 2025-03-31 0001739104 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2025-01-01 2025-03-31 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001739104 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001739104 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001739104 us-gaap:CommonStockMember 2025-03-31 0001739104 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001739104 us-gaap:RetainedEarningsMember 2025-03-31 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-03-31 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2025-03-31 0001739104 us-gaap:AccumulatedDefinedBenefitPlansAd